These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12712415)

  • 61. [Tuberculous cold abscess following injection of diptheria-tetanus vaccine].
    SCHNEEGANS ME; MICHEL M
    Strasb Med; 1956 May; 7(5):338-42. PubMed ID: 13337594
    [No Abstract]   [Full Text] [Related]  

  • 62. Potency control of diphtheria component in adsorbed vaccines by in vitro neutralization tests.
    Marcovistz R; Matos DC; Georgini RA; Sakauchi D
    Biologicals; 2002 Jun; 30(2):105-12. PubMed ID: 12127312
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules.
    Singh M; Singh A; Talwar GP
    Pharm Res; 1991 Jul; 8(7):958-61. PubMed ID: 1924151
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A thermostable tetanus/diphtheria (Td) vaccine in the StablevaX™ pre-filled delivery system.
    de la Torre Arrieta J; Briceño D; de Castro IG; Roser B
    Vaccine; 2023 May; 41(22):3413-3421. PubMed ID: 37121799
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.
    Kersten GF; Donders D; Akkermans A; Beuvery EC
    Vaccine; 1996 Dec; 14(17-18):1627-32. PubMed ID: 9032891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Summaries for patients. Immunity to diphtheria and tetanus in the United States.
    Ann Intern Med; 2002 May; 136(9):I30. PubMed ID: 11992321
    [No Abstract]   [Full Text] [Related]  

  • 67. Immunity to diphtheria and tetanus among blood donors in Arak, central province of Iran.
    Eslamifar A; Ramezani A; Banifazl M; Sofian M; Mahdaviani FA; Yaghmaie F; Aghakhani A
    Iran J Microbiol; 2014 Jun; 6(3):190-3. PubMed ID: 25870753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined Poly(Lactide-Co-Glycolide) Microspheres Containing Diphtheria Toxoid for a Single-shot Immunization.
    Woo HS; Kim SR; Yoon M; Lee ES; Chang IH; Whang YM; Lee DI; Kang MJ; Choi YW
    AAPS PharmSciTech; 2018 Apr; 19(3):1160-1167. PubMed ID: 29238945
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
    He Y; Chen ZH; Wei SL
    Yao Xue Xue Bao; 2001 Sep; 36(9):695-8. PubMed ID: 12580111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The potentiation of vaccines by aluminum oxide adsorption. 2. Aluminum oxide-poliomyelitis-diphtheria-tetanus vaccine].
    GRAFE A; KUHN RB
    Arzneimittelforschung; 1962 Apr; 12():392-5. PubMed ID: 13900987
    [No Abstract]   [Full Text] [Related]  

  • 71. Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies.
    Einarsdottir S; Ljungman P; Kaijser B; Nicklasson M; Horal P; Norder H; Bergström T; Brune M
    Vaccine; 2020 Jan; 38(5):1084-1088. PubMed ID: 31787417
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization.
    Maa YF; Shu C; Ameri M; Zuleger C; Che J; Osorio JE; Payne LG; Chen D
    Pharm Res; 2003 Jul; 20(7):969-77. PubMed ID: 12880281
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Poly (D,L-lactide) glycolide polymer microsphere entrapped tetanus toxoid: safety evaluation in Wistar rats.
    Chaudhury MR; Sharma K; Giri DK
    Hum Exp Toxicol; 1996 Mar; 15(3):205-7. PubMed ID: 8839206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [On the complications of diphtheria-tetanus anatoxin vaccination].
    RAMON G
    Vie Med; 1951 Oct; 32(10):9-13. PubMed ID: 14884474
    [No Abstract]   [Full Text] [Related]  

  • 75. Diphtheria and tetanus immunity.
    Balestra DJ
    Ann Intern Med; 2002 Nov; 137(9):774-5; author reply 774-5. PubMed ID: 12416962
    [No Abstract]   [Full Text] [Related]  

  • 76. The immunity responses of mice to injections of diphtheria and tetanus prophylactics.
    BARR M; FULTHORPE AJ; LLEWELLYN-JONES M
    Br J Exp Pathol; 1957 Jun; 38(3):312-8. PubMed ID: 13436727
    [No Abstract]   [Full Text] [Related]  

  • 77. Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable microspheres along with alum.
    Diwan M; Dawar H; Talwar GP
    Prostate; 1998 Jun; 35(4):279-84. PubMed ID: 9609551
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Technological considerations related to the up-scaling of protein microencapsulation by spray-drying.
    Johansen P; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2000 Nov; 50(3):413-7. PubMed ID: 11072199
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microencapsulated vaccines to provide prolonged immunity with a single administration.
    Whalen RL; Dempsey DJ; Thompson LM; Bucknell K; Kunitomo R; Okazaki Y; Harasaki H
    ASAIO J; 1996; 42(5):M649-54. PubMed ID: 8944961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tetanus-diphtheria booster in non-responding tetanus-diphtheria vaccinees.
    Van der Wielen M; Van Damme P
    Vaccine; 2000 Dec; 19(9-10):1005-6. PubMed ID: 11203498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.